Metraipolis › archive › dc_eb8b8aa78aaf

QBP1 Peptide as a Potential Anti-Amyloidogenic Therapy for Type 2 Diabetes: An In Vitro Study — Europe PMC PMID:42017387

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42017387
DOI
10.1002/advs.202508344
License (as archived)
solo-consultazione
Archived
2026-11-03T07:29:39.368Z
SHA-256 of the archived text
fe75980fed667d011c0feb516ccd8496ffe01b5a60a0af98996ac2715a41c3c5
Stable URL of this page
https://metraipolis.com/documento/dc_eb8b8aa78aaf

How to cite

QBP1 Peptide as a Potential Anti-Amyloidogenic Therapy for Type 2 Diabetes: An In Vitro Study — Europe PMC PMID:42017387 — Europe PMC (en), https://europepmc.org/article/MED/42017387 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eb8b8aa78aaf (Metraipolis archive dc_eb8b8aa78aaf, sha256 fe75980fed667d011c0feb516ccd8496ffe01b5a60a0af98996ac2715a41c3c5)
BibTeX
@misc{dceb8b8aa78aaf,
  title = {QBP1 Peptide as a Potential Anti-Amyloidogenic Therapy for Type 2 Diabetes: An In Vitro Study — Europe PMC PMID:42017387},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42017387},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eb8b8aa78aaf; sha256 fe75980fed667d011c0feb516ccd8496ffe01b5a60a0af98996ac2715a41c3c5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42017387. Agents can read the archived copy with the MCP tool read_document.